BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1230 related articles for article (PubMed ID: 24810656)

  • 21. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
    Zerr DM; Boeckh M; Delaney C; Martin PJ; Xie H; Adler AL; Huang ML; Corey L; Leisenring WM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1700-8. PubMed ID: 22641196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
    Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
    Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
    Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
    Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation].
    Lu Y; Wu T; Cao XY; Wang JB; Sun Y; Zhao YL; DA WM; Ji SQ; Tong CR; Lu DP
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):383-7. PubMed ID: 21624219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Herpes Virus-6 Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
    Shachor-Meyouhas Y; Fesenko A; Kra-Oz Z; Zaidman I; Szwarcwort-Cohen M; Shafran E; Kassis I
    Isr Med Assoc J; 2015 May; 17(5):302-5. PubMed ID: 26137657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous Quantification of the 8 Human Herpesviruses in Allogeneic Hematopoietic Stem Cell Transplantation.
    Gomes de Oliveira PG; Ueda MY; Real JM; de Sá Moreira E; Rodrigues de Oliveira JS; Gonçalves MV; Ginani VC; de Oliveira Felix OM; Seber A; Novis Y; Rocha V; Granato CF; Arrais-Rodrigues C
    Transplantation; 2016 Jun; 100(6):1363-70. PubMed ID: 26555946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
    J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation.
    Watanabe M; Kanda J; Hishizawa M; Kondo T; Yamashita K; Takaori-Kondo A
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):587-593. PubMed ID: 30359733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
    de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
    Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
    Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
    Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
    Cantoni N; Hirsch HH; Khanna N; Gerull S; Buser A; Bucher C; Halter J; Heim D; Tichelli A; Gratwohl A; Stern M
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1309-14. PubMed ID: 20353832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.
    Mutlu D; Uygun V; Yazisiz H; Tezcan G; Hazar V; Colak D
    Ann Saudi Med; 2014; 34(1):6-11. PubMed ID: 24658548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study on modulation of immunosuppression for Epstein-Barr virus reactivation in pediatric patients who underwent unrelated hematopoietic stem-cell transplantation.
    Cesaro S; Pegoraro A; Tridello G; Calore E; Pillon M; Varotto S; Abate D; Barzon L; Mengoli C; Carli M; Messina C
    Transplantation; 2010 Jun; 89(12):1533-40. PubMed ID: 20463647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.